True 2 Beauty Inc. (TRTB.PK) CEO Invited to Present at the Undiscovered Equities Winter Conference

QualityStocks would like to highlight True 2 Beauty (PINKSHEETS: TRTB) is a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States. The True 2 Beauty, Inc. line of current products includes Libigrow, Libigirl, Libiliquid Shots, and the Libiliquid Relaxation Drink.

In the company’s news today,

True 2 Beauty was pleased to announce that it has been invited to present at its first investor conference.

CEO Alex Hbaiu will present to an invitation only audience compromised of accredited investors, retail brokers, and institutional investors. The Undiscovered Equities Winter Conference will be held in Boca Raton on March 2 and 3, 2011. Mr. Hbaiu will outline True 2 Beauty’s current operations and strategic plans for future growth.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.